BioUtah Participates in National Symposium on Biotechnology's Role in National Security

BioUtah participated in the Biotech Across America State Symposium in Washington, D.C. on March 25, 2026, focusing on the strategic importance of robust state and local biotechnology ecosystems for national security and economic resilience. The event represents a continuation of the National Security Commission on Emerging Biotechnology's Biotech Across America Roadshow, which aims to highlight biotechnology developments across the United States. Utah's biotechnology sector demonstrates substantial national contributions, with the state recognized for its startup environment, employment of 180,000 people in life sciences, and generation of $22 billion in GDP.

The symposium emphasized how regional biotechnology strengths collectively bolster national capabilities. The National Security Commission on Emerging Biotechnology, established as a legislative advisory entity, works to advance and secure biotechnology and biomanufacturing for U.S. national security preparedness. The Commission published a comprehensive report in April 2025 with recommendations for Congressional and federal action, available at https://biotech.senate.gov. This report informs ongoing discussions about positioning the United States for what the Commission terms the bioindustrial revolution.

Utah's biotechnology ecosystem includes diverse sectors such as medical device manufacturing, research and testing, biotechnology, biopharmaceuticals, and diagnostics. BioUtah, as the state's life sciences trade association, represents these industries and their economic significance. The Federation of American Scientists, an organization established in 1945 to bring scientific expertise to policymaking, contributes to these national conversations through its work at https://fas.org. Similarly, the Engineering Biology Research Consortium serves as a nonprofit partnership advancing engineering biology to address national and global needs.

The Biotech Across America initiative underscores the interconnectedness of state-level innovation and federal strategic priorities. By convening stakeholders from industry, academia, and government, the symposium facilitates knowledge exchange about workforce development programs, policy initiatives, and research advancements driving biotechnology growth. These discussions occur against a backdrop of increasing recognition that biotechnology advancements have implications beyond healthcare, extending to economic competitiveness and national security dimensions that require coordinated public-private approaches.